| Title | Preimplantation Genetic Testing Market - Business Overview, Industry Growth and Forecast upto 2031 |
|---|
| URL | https://bisresearch.com/industry-report/preimplantation-genetic-testing-market.html |
|---|
| Category | Business --> Healthcare |
|---|
| Meta Keywords | Preimplantation Genetic Testing Market, Preimplantation Genetic Testing Market Report
|
|---|
| Meta Description | Preimplantation Genetic Testing Market was valued at $972.1 million in 2020 and is expected to reach $2,725.7 million by 2031, registering a CAGR of 9.69% during the forecast period 2021-2031. |
|---|
| Owner | BIS Research |
|---|
| Description |
|---|
| Preimplantation genetic diagnosis (PGD) is performed among couples that have a higher risk of transmitting a genetic condition to their offspring. The technique is employed in in-vitro fertilization centers globally to select the euploid embryos to transfer and improve the clinical outcome of the clinical pregnancy, embryo implantation, and live birth rates. The ability to identify the preimplantation embryos with the genetic defects prior to the initiation of the pregnancy also offers an attractive alternative to chorionic villus sampling or amniocentesis.
The preimplantation genetic testing is set to grow at a significant rate in the upcoming years as the technology and awareness regarding the test improve.
Preimplantation Genetic Testing Market was valued at $972.1 million in 2020 and is expected to reach $2,725.7 million by 2031, registering a CAGR of 9.69% during the forecast period 2021-2031.
|
